References
-
1a
Cole C.
Foster AJ.
Freeman S.
Jaffar M.
Murray PE.
Stratford IJ.
Anti-Cancer Drug Des.
1999,
14:
383
-
1b
Gumina G.
Song GY.
Chu CK.
FEMS Microbiol. Lett.
2001,
202:
9
-
2a
Kappe CO.
Roschger PJ.
J. Heterocycl. Chem.
1989,
26:
55 ; and references cited therein
-
2b
Kappe CO.
Tetrahedron
1993,
49:
6937
-
3a
Mai A.
Marino A.
Sbardella G.
Massa S.
Loi AG.
Tramontano E.
Scano P.
La Colla P.
J. Med. Chem.
1995,
38:
3258
-
3b
Mai A.
Artico M.
Ragno R.
Sbardella G.
Massa S.
Musiu C.
Mura M.
Marturana F.
Cadeddu F.
Maga G.
La Colla P.
Bioorg. Med. Chem.
2005,
13:
2065
-
3c
Bajaj S.
Sambi SS.
Madan AK.
Bioorg. Med. Chem. Lett.
2005,
15:
467
-
3d
Ragno R.
Frasca S.
Manetti F.
Brizzi A.
Massa S.
J. Med. Chem.
2005,
48:
200
-
3e
Botta M.
Occhionero F.
Nicoletti R.
Mastromarino P.
Conti C.
Magrini M.
Saladino R.
Bioorg. Med. Chem.
1999,
7:
1925
- 4
Yuskovets VN.
Ivin BA.
Tetrahedron Lett.
2003,
44:
5279
-
5a
Brown DJ. In
Comprehensive Heterocyclic Chemistry
Vol. 3:
Katritzky AR.
Rees CW.
Pergamon;
Oxford:
1984.
-
5b
Sarabia F.
Martin-Ortiz L.
Lopez-Herrera FJ.
Org. Biomol. Chem.
2003,
1:
3716
-
5c
Malik V.
Singh P.
Kumar S.
Tetrahedron
2005,
61:
4009
-
5d
Friot C.
Reliquet A.
Reliquet F.
Meslin JC.
Synthesis
2000,
695
-
5e
Landreau C.
Deniaud D.
Reliquet A.
Reliquet F.
Meslin JC.
J. Heterocycl. Chem.
2001,
38:
93
-
6a
Joule JA.
Mills K.
In Heterocyclic Chemistry
4th ed.:
Mead O.
Blackwell Science;
Oxford:
2000.
-
6b
Stanovnik B.
Svete J.
Chem. Rev.
2004,
104:
2433
- 7
Hronowski LJJ.
Szarek WA.
Can. J. Chem.
1985,
63:
2787
-
8a
Jayakumar S.
Ishar MPS.
Mahajan MP.
Tetrahedron
2002,
58:
379
-
8b
Abbiati G.
Cirrincione de Carvalho A.
Rossi E.
Tetrahedron
2003,
59:
7397
-
8c
Mohan C.
Kumar V.
Mahajan MP.
Tetrahedron Lett.
2004,
45:
6075
-
8d
Jayakumar S.
Singh P.
Mahajan MP.
Tetrahedron
2004,
60:
4315
-
8e
Landreau C.
Deniaud D.
Meslin JC.
J. Org. Chem.
2003,
68:
4912
-
8f
Landreau C.
Deniaud D.
Reliquet A.
Meslin JC.
Eur. J. Org. Chem.
2003,
3:
421
- 9
Pearson MSM.
Robin A.
Bourgougnon N.
Meslin JC.
Deniaud D.
J. Org. Chem.
2003,
68:
8583
- 10
Herrera A.
Martinez-Alvarez R.
Ramiro P.
Tetrahedron
2003,
59:
7331
-
11a
Robin A.
Meslin JC.
Deniaud D.
Synthesis
2004,
1633
-
11b
Robin A.
Julienne K.
Meslin JC.
Deniaud D.
Tetrahedron Lett.
2004,
45:
9557
-
13a
Hori M.
Kataoka T.
Shimizu H.
Imai E.
Yokomoto M.
Ando Y.
Synthesis
1987,
278
-
13b
Tea-Gokou C.
Pradère JP.
Bujoli B.
Quiniou H.
Toupet L.
Bull. Soc. Chim. Fr.
1987,
1:
149
-
13c
Zigeuner G.
Schweiger K.
Fuchsgruber A.
Monatsh. Chem.
1981,
112:
187
-
14a
Masuda R.
Hojo M.
Ichii T.
Sasano S.
Kobayashi T.
Kuroda C.
Tetrahedron Lett.
1991,
32:
1195
-
14b
Mohammadpoor-Baltork I.
Khodaei MM.
Nikoofar K.
Tetrahedron Lett.
2003,
44:
591
-
15a
Mohammadpoor-Baltork I.
Sadeghi MM.
Esmayilpour K.
Phosphorus, Sulfur Silicon Relat. Elem.
2003,
178:
61
-
15b
Greenhalgh RP.
Synlett
1992,
235
12
Methylsulfanylpyrimidinethiones 3.
Isothiocyanate (2.2 mmol) was added to a solution of diazadienium iodide 1 (272 mg, 1.0 mmol) in CH2Cl2 (10 mL). After 15 min, Et3N (300 µL, 2.2 mmol) was added and the reaction mixture was stirred at r.t. over a period of 4 h for 3a and 4 h for 3b. Then, the organic mixture was washed twice with H2O, dried over MgSO4 and concentrated under vacuum. The residue was purified by chromatography on silica gel (CH2Cl2-PE-Et3N, 50:47:3).
Spectroscopic data of compound 3a: IR (KBr): ν = 1605, 1589, 1481, 1405, 1323, 1175 cm-1. 1H NMR (200 MHz, CDCl3): δ = 2.66 (s, 3 H, CH
3S), 6.60 (d, 1 H, 3
J = 7.0 Hz, CH-5), 7.40 (m, 5 H, 5 × CH
ar), 7.43 (d, 1 H, 3
J = 7.0 Hz, CH-6). 13C NMR (50 MHz, CDCl3): δ = 13.2 (CH3S), 107.7 (CH-5), 126.6 (2 × CHar), 129.3 (CHar), 129.9 (2 × CHar), 144.0 (2 C, CH-6 and C
ar), 173.4 (C-4), 182.0 (CS). Mp 173-175 °C. HRMS (ESI+): m/z calcd for C11H10N2S2Na [M + Na]+: 257.0183; found: 257.0182.
16
Methylthiouracils 6.
Oxone® (1.23 g, 2.0 mmol) and wet alumina (1.0 g) were added to a solution of methylsulfanylpyrimidinethiones (1.0 mmol) in CH2Cl2 (15 mL). The reaction mixture was stirred at r.t. for 48 h. Then, the inorganic salts were removed by filtration and the filtrate was concentrated under vacuum. The residue was purified by chromatography on silica gel (CH2Cl2-PE-Et3N, 90:7:3).
Spectroscopic data of compound 6a: IR (KBr): ν = 1664, 1614, 1493, 1287 cm-1. 1H NMR (200 MHz, CDCl3): δ = 2.52 (s, 3 H, CH
3S), 6.22 (d, 1 H, 3
J = 7.0 Hz, CH-5), 7.28 (m, 6 H, 5 × CH
ar and CH-6). 13C NMR (50 MHz, CDCl3): δ = 13.0 (CH3S), 103.7 (CH-5), 126.1 (2 × CHar), 128.7 (CHar), 129.5 (2 × CHar), 140.3 (C
ar), 144.0 (CH-6), 153.9 (CO), 178.6 (C-4). Mp 156-158 °C. HRMS (ESI+): m/z calcd for C11H10N2OSNa [M + Na]+: 241.0412; found: 241.0410.
17 Spectroscopic data of compound 7b: IR (KBr): ν = 1742, 1734, 1719, 1630, 1325, 1109 cm-1. 1H NMR (400 MHz, DMSO-d
6): δ = 3.25 (s, 3 H, CH
3N), 6.22 (d, 1 H, 3
J = 6.8 Hz, CH-5), 7.53 (d, 1 H, 3
J = 6.8 Hz, CH-6). 13C NMR (50 MHz, DMSO-d
6): δ = 36.0 (CH3N), 111.7 (CH-5), 142.4 (CH-6), 148.8 (CO), 190.1 (CS). Mp 193-196 °C. HRMS (ESI+): m/z calcd for C5H6N2SONa [M + Na]+: 165.0099; found: 165.0098.
Spectroscopic data of compound 8b: IR (KBr): ν = 1695, 1423, 1379, 1331. 1H NMR (400 MHz, DMSO-d
6): δ = 3.21 (s, 3 H, CH
3N), 5.51 (d, 1 H, 3
J = 8.0 Hz, CH-5), 7.60 (d, 1 H, 3
J = 8.0 Hz, CH-6). 13C NMR (50 MHz, DMSO-d
6): δ = 34.4 (CH3N), 99.7 (CH-5), 145.6 (CH-6), 150.5 (CO-2), 163.1 (CO-4). Mp 229-234 °C. HRMS (ESI+): m/z calcd for C5H6N2O2Na [M + Na]+: 149.0327; found: 149.0325.